Ann Holder on fetal monitoring
From Revolutionizing Maternity Care: Ann Holder's Vision for AI-Monitored Pregnancy with MARANI · · MindMomBodyRN
“The first thing we had to do was develop a device where we could actually capture the fetal ECG and the maternal ECG — which has never been done until now.”
On , Ann Holder, Cofounder at Marani, spoke about fetal monitoring during Revolutionizing Maternity Care: Ann Holder's Vision for AI-Monitored Pregnancy with MARANI on MindMomBodyRN.
About Ann Holder
Ann Holder, cofounder of Marani Health, has been discussing the company's development of a new device for maternal and fetal monitoring during pregnancy. Holder stated that the device, which captures both fetal and maternal electrocardiograms, was developed in collaboration with the Mayo Clinic. She noted that the technology is intended to address what she described as outdated monitoring methods and to provide earlier detection of potential issues, such as gestational hypertension. Holder also commented on challenges in the field, including the closure of obstetrics services in rural hospitals and what she characterized as a high rate of potentially unnecessary cesarean sections. Holder has spoken about difficulties in fundraising, stating that only 2% of venture capital funding goes to women. She called for more investment in women's health, describing it as a mission-driven need. Holder also addressed concerns about artificial intelligence in medicine, comparing resistance to new technology to historical reactions to the printing press.